No, really, how do they work?

Genes and Development

Volumn 19, Issue 4, 2005, Pages 413-414

  Moore, David D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; GLYCEROL KINASE; HISTONE; HISTONE DEACETYLASE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RESISTIN; RETINOID X RECEPTOR; RNA POLYMERASE; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; DRUG BINDING SITE; HIGH THROUGHPUT SCREENING; INSULIN RESISTANCE; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION INITIATION;

ADIPOSE TISSUE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; HYPOGLYCEMIC AGENTS; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 13844264424     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1294105     Document Type: Review

References (8)

1. Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M. 1995. 15-Deoxy-δ 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR γ. Cell 83: 803-812.
2. Fujita, T., Sugiyama, Y., Taketomi, S., Sohda, T., Kawamatsu, Y., Iwatsuka, H., and Suzuoki, Z. 1983. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine- 2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Diabetes 32: 804-810.
3. Guan, H.-P., Ishizuka, T., Chui, P.C., Lehrke, M., and Lazar, M.A. 2005. Corepressors selectively control the transcriptional activity of PPARγ in adipocytes. Genes & Dev. (this issue).
4. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M., and Kliewer, S.A. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J. Biol. Chem. 270: 12953-12956.
5. Picard, F. and Auwerx, J. 2002. PPAR(γ) and glucose homeostasis. Annu. Rev. Nutr. 22: 167-197.
6. Rangwala, S.M. and Lazar, M.A. 2004. Peroxisome proliferator-activated receptor γ in diabetes and metabolism. Trends Pharmacol. Sci. 25: 331-336.
7. Tzameli, I., Fang, H., Ollero, M., Shi, H., Hamm, J.K., Kievit, P., Hollenberg, A.N., and Flier, J.S. 2004. Regulated production of a peroxisome proliferator-activated receptor-γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 279: 36093-36102.
8. Wagner, B.L., Valledor, A.F., Shao, G., Daige, C.L., Bischoff, E.D., Petrowski, M., Jepsen, K., Baek, S.H., Heyman, R.A., Rosenfeld, M.G., et al. 2003. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression. Mol. Cell Biol. 23: 5780-5789.